CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

CDER Patient-Focused Drug Development

Neutral
AI Analysis

Summary

FDA CDER provides guidance on patient-focused drug development (PFDD), a systematic approach to incorporate patient experiences, perspectives, needs, and priorities into drug development and evaluation. This is a routine informational update on regulatory methodology.

Importance:2/10
Sentiment:
0.00
patient-focused drug developmentPFDDregulatory guidanceFDA CDER
Related Companies

Read the original article

Published by FDA Drugs (New Approvals & NDA) on September 29, 2026 11:07 PM

Read Original